Skip to content
DraconiticResearch
Search Sources API
197,787 studies31 sourcesUpdated 46 min ago
Peer-reviewedCC BY 4.0Frontiers in Microbiology

Metabolic-epigenetic regulation of the HBV cccDNA reservoir: pathways underpinning viral persistence

  • Qing Peng1,2
  • Liyuan Hao3
  • Shenghao Li4
  • Fei Yu1,2
  • Na Li1,2
  • Fanghang Ye1,2
  • Xiaoyu Hu2
4 affiliations
  1. 1Clinical Medical College, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China
  2. 2Department of Infectious Diseases, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China
  3. 3School of Integrated Traditional Chinese and Western Medicine, Hebei University of Chinese Medicine, Shijiazhuang, Hebei, China
  4. 4Department of Integrated Traditional Chinese and Western Medicine Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China
Read full textPDFDOICite

Abstract

Chronic hepatitis B virus (HBV) infection remains a global public health burden, and functional cure represents the primary goal of clinical management. The nuclear covalently closed circular DNA (cccDNA) minichromosome stably maintained in infected hepatocytes constitutes the major barrier to HBV cure. Clinically, functional cure is defined as sustained hepatitis B surface antigen (HBsAg) seroclearance with undetectable serum HBV DNA after finite treatment, a definition that does not require complete cccDNA elimination. At the molecular level, functional cure is thought to be associated with stable transcriptional silencing of cccDNA and integrated HBV DNA, a state biologically distinct from physical cccDNA depletion. Accumulating data demonstrate that the persistence and transcriptional homeostasis of the cccDNA reservoir are controlled by viral proteins and dynamically shaped by host metabolic signaling and epigenetic remodeling. Here, we first outline key steps of the HBV life cycle to establish the mechanistic context for cccDNA formation and replenishment, and then focus our synthesis on the integrated host metabolic-epigenetic network that governs cccDNA establishment, transcriptional activity, stability, and clearance. We dissect how central carbon metabolites, bile acid signaling, histone post-translational modifications, and immune cytokines converge to modulate cccDNA reservoir homeostasis, and critically evaluate the strength of evidence supporting their physiological relevance in the chronically infected human liver. We also discuss mechanisms of HBV immune evasion, including hepatitis B virus X protein (HBx)-driven epigenetic reprogramming and subviral particle-associated immune tolerance. We summarize preclinical and clinical therapeutic strategies targeting the metabolic-epigenetic microenvironment, viral assembly, antigen secretion, and cccDNA modulation to achieve a functional cure for HBV infection. Finally, we outline key unresolved challenges in the field, including the undefined in vivo cccDNA turnover kinetics, the poorly characterized physiological relevance of cell-to-cell transmission, the inherent limitations of gene-editing technologies, and the urgent need for specific non-invasive biomarkers reflecting intrahepatic cccDNA activity.

Related

  1. Lactylation in cancer: a new frontier in metabolic-epigenetic regulation and clinical practice.
    Yihan Zhang, Lan Chen, Yaxi Qin +4
    Cell communication and signaling : CCSPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCDOAJ
  2. Uncovering LINC02982: a T-ALL-specific lncrna linking epigenetic regulation and metabolic pathways
    Giovanni Pecoraro, Katia Pane, Monica Franzese +4
    Cancer Cell InternationalPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  3. Culture Dimensionality Shapes Drug Sensitivity to Kinase Inhibitor Combinations with Epigenetic or Metabolic Inhibition in a Hepatocellular Carcinoma Model
    Claudia Kunst, Tobias Schilling, Cedric Arling +4
    BiomedicinesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Epigenetic regulation of cancer stem cell plasticity and relapse competence in EGFR-mutant lung cancer
    Xiangxiang Sun, Shengshan Xu, Qian Guo
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMCEurope PMC
  5. Astrocytic Ketogenesis Protects Central Nervous System Injury via CPT1A Stabilization and Epigenetic Regulation.
    Dishui Pan, Haoming Shu, Rui Gao +12
    Advanced science (Weinheim, Baden-Wurttemberg, Germany)Peer-reviewedCC BYFull textGeneral medicineEurope PMC

Cite

BibTeXRIS
BibTeX
@article{peng2026metabolicepigenetic,
  title = {{Metabolic-epigenetic regulation of the HBV cccDNA reservoir: pathways underpinning viral persistence}},
  author = {Qing Peng and Liyuan Hao and Shenghao Li and Fei Yu and Na Li and Fanghang Ye and Xiaoyu Hu},
  journal = {Frontiers in Microbiology},
  year = {2026},
  month = oct,
  doi = {10.3389/fmicb.2026.1968789},
  url = {https://doi.org/10.3389/fmicb.2026.1968789},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Metabolic-epigenetic regulation of the HBV cccDNA reservoir: pathways underpinning viral persistence
AU  - Qing Peng
AU  - Liyuan Hao
AU  - Shenghao Li
AU  - Fei Yu
AU  - Na Li
AU  - Fanghang Ye
AU  - Xiaoyu Hu
PY  - 2026
DA  - 2026/10/12
JO  - Frontiers in Microbiology
DO  - 10.3389/fmicb.2026.1968789
UR  - https://doi.org/10.3389/fmicb.2026.1968789
AB  - Chronic hepatitis B virus (HBV) infection remains a global public health burden, and functional cure represents the primary goal of clinical management. The nuclear covalently closed circular DNA (cccDNA) minichromosome stably maintained in infected hepatocytes constitutes the major barrier to HBV cure. Clinically, functional cure is defined as sustained hepatitis B surface antigen (HBsAg) seroclearance with undetectable serum HBV DNA after finite treatment, a definition that does not require complete cccDNA elimination. At the molecular level, functional cure is thought to be associated with stable transcriptional silencing of cccDNA and integrated HBV DNA, a state biologically distinct from physical cccDNA depletion. Accumulating data demonstrate that the persistence and transcriptional homeostasis of the cccDNA reservoir are controlled by viral proteins and dynamically shaped by host metabolic signaling and epigenetic remodeling. Here, we first outline key steps of the HBV life cycle to establish the mechanistic context for cccDNA formation and replenishment, and then focus our synthesis on the integrated host metabolic-epigenetic network that governs cccDNA establishment, transcriptional activity, stability, and clearance. We dissect how central carbon metabolites, bile acid signaling, histone post-translational modifications, and immune cytokines converge to modulate cccDNA reservoir homeostasis, and critically evaluate the strength of evidence supporting their physiological relevance in the chronically infected human liver. We also discuss mechanisms of HBV immune evasion, including hepatitis B virus X protein (HBx)-driven epigenetic reprogramming and subviral particle-associated immune tolerance. We summarize preclinical and clinical therapeutic strategies targeting the metabolic-epigenetic microenvironment, viral assembly, antigen secretion, and cccDNA modulation to achieve a functional cure for HBV infection. Finally, we outline key unresolved challenges in the field, including the undefined in vivo cccDNA turnover kinetics, the poorly characterized physiological relevance of cell-to-cell transmission, the inherent limitations of gene-editing technologies, and the urgent need for specific non-invasive biomarkers reflecting intrahepatic cccDNA activity.
SN  - 1664-302X
ER  -